Physician profile
Damien Lucius
NPI 1235150665
$6,657.33
in general payments reported to CMS, 2019-2025
10 companies · $2,225 in 2025
The $2,225 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $1,402 · 2021: $654 · 2022: $955 · 2023: $1,131 · 2024: $158 · 2025: $2,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,765 · Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,764.67 |
| Food and Beverage | $749.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $6,324.87 | 2020-2025 | |
| Wright Medical Technology, INC. | $94.35 | 2019 | |
| Osteomed LLC | $49.93 | 2019-2021 | |
| Orthofix Medical, INC. | $48.80 | 2021-2022 | |
| Smith+Nephew, INC. | $32.50 | 2021-2023 | Stravix Pl, Grafix Pl |
| Kairos Surgical INC | $29.57 | 2025 | |
| Arthrosurface Incorporated | $24.17 | 2019-2020 | |
| Medtronic, INC. | $22.18 | 2025 | Intellis Adaptivestim |
| Stryker Corporation | $17.32 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.64 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damien Lucius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.